Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An updated review on activated PI3 kinase delta syndrome (APDS)

14 Oct 2019

Abstract excerpt

Activated Phosphoinositide 3-kinase δ syndrome (APDS) is a newly recognised primary immunodeficiency disease. It has currently been a hot topic of clinical research and new data are emerging regarding its pathogenesis, clinical manifestations and treatment. Patients with APDS syndrome have significant autoimmune manifestations and lymphoproliferation. It is important to differentiate APDS from the usual polygenic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood disorders and treatments
Share to Chronic Lymphocytic Leukemia Research
Share to Immunodeficiency and Autoimmune Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32181277
DOI: 10.1016/j.gendis.2019.09.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An updated review on activated PI3 kinase delta syndrome (APDS)PMID 32181277Read ↗

Disorders Related to PI3Kδ Hyperactivation: Characterizing the Clinical and Immunological Features of Activated PI3-Kinase Delta SyndromesSemantic proximity Read ↗

Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy.Semantic proximity Read ↗

Activated PI3Kinase Delta Syndrome—A Multifaceted DiseaseSemantic proximity Read ↗

The Treatment of Activated PI3Kδ SyndromeSemantic proximity Read ↗

Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.Semantic proximity Read ↗

Activated phosphoinositide 3-dinase delta syndrome (APDS): An update.Semantic proximity Read ↗

Infections in activated PI3K delta syndrome (APDS).Semantic proximity Read ↗

Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.Semantic proximity Read ↗

Activated phosphoinositide 3‐kinase delta syndrome: Pathogenesis, clinical manifestations, and treatmentSemantic proximity Read ↗

The First Iranian Cohort of Pediatric Patients with Activated Phosphoinositide 3-Kinase-δ (PI3Kδ) Syndrome (APDS).Semantic proximity Read ↗

Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort.Semantic proximity Read ↗

Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in JapanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.